
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr. Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.

21,968 Listeners

43,986 Listeners

32,105 Listeners

38,509 Listeners

6,769 Listeners

43,647 Listeners

27,173 Listeners

2,874 Listeners

9,213 Listeners

468 Listeners

734 Listeners

944 Listeners

6,423 Listeners

921 Listeners

98 Listeners